[HTML][HTML] The good, the bad, and the opportunities of the complement system in neurodegenerative disease

ND Schartz, AJ Tenner - Journal of Neuroinflammation, 2020 - Springer
The complement cascade is a critical effector mechanism of the innate immune system that
contributes to the rapid clearance of pathogens and dead or dying cells, as well as …

Present and future of microglial pharmacology

E Šimončičová, EG de Andrade, HA Vecchiarelli… - Trends in …, 2022 - cell.com
Microglia, brain resident immune cells, modulate development, activity, and plasticity of the
central nervous system. Mechanistically implicated in numerous neurological pathologies …

Soluble biomarkers of cerebrovascular pathologies

KE Foley, DM Wilcock - Stroke, 2024 - Am Heart Assoc
Vascular contributions to cognitive impairment and dementia (VCID) is an all-encompassing
term that describes cognitive impairment due to cerebrovascular origins. With the …

Plasma inflammatory biomarkers are associated with poststroke cognitive impairment: the nor-COAST study

HV Sandvig, S Aam, KN Alme, T Askim, MK Beyer… - Stroke, 2023 - Am Heart Assoc
Background: Inflammation is proposed to be involved in the pathogenesis of poststroke
cognitive impairment. The aim of this study was to investigate associations between …

[HTML][HTML] Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies

G Magni, B Riboldi, S Ceruti - Cells, 2024 - mdpi.com
In vitro and preclinical in vivo research in the last 35 years has clearly highlighted the crucial
physiopathological role of glial cells, namely astrocytes/microglia/oligodendrocytes and …

[HTML][HTML] Exogenous inter-α inhibitor proteins prevent cell death and improve ischemic stroke outcomes in mice

LD McCullough, M Roy-O'Reilly, YJ Lai… - The Journal of …, 2021 - Am Soc Clin Investig
Inter-α inhibitor proteins (IAIPs) are a family of endogenous plasma and extracellular matrix
molecules. IAIPs suppress proinflammatory cytokines, limit excess complement activation …

Biology-driven material design for ischaemic stroke repair

NV Phan, EM Rathbun, Y Ouyang… - Nature Reviews …, 2024 - nature.com
Ischaemic stroke remains a leading cause of disability, with current clinical treatment options
mainly focusing on mitigating immediate damage. The limited self-renewing capacity of the …

Reeling in complement in transplant‐associated thrombotic microangiopathy: You're going to need a bigger boat

S Jodele, A Sabulski - American Journal of Hematology, 2023 - Wiley Online Library
Over the last decade there have been numerous advances in both the diagnosis and
treatment of transplant‐associated thrombotic microangiopathy (TA‐TMA). These are largely …

[HTML][HTML] NPD1 plus RvD1 mediated ischemic stroke penumbra protection increases expression of pro-homeostatic microglial and astrocyte genes

MM Reid, MAI Kautzmann, G Andrew… - Cellular and Molecular …, 2023 - Springer
Neuroprotection to attenuate or block the ischemic cascade and salvage neuronal damage
has been extensively explored for treating ischemic stroke. However, despite increasing …

[HTML][HTML] Free complement and complement containing extracellular vesicles as potential biomarkers for neuroinflammatory and neurodegenerative disorders

M Burgelman, P Dujardin, C Vandendriessche… - Frontiers in …, 2023 - frontiersin.org
The complement system is implicated in a broad range of neuroinflammatory disorders such
as Alzheimer's disease (AD) and multiple sclerosis (MS). Consequently, measuring …